Home Other Building Blocks 2,6-Dimethylaniline HCl

2,6-Dimethylaniline HCl

CAS No.:
21436-98-6
Catalog Number:
AG00331U
Molecular Formula:
C8H12ClN
Molecular Weight:
157.6406
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$13
- +
5g
98%
In Stock USA
United States
$32
- +
25g
98%
In Stock USA
United States
$88
- +
100g
98%
In Stock USA
United States
$238
- +
500g
98%
In Stock USA
United States
$713
- +
Product Description
Catalog Number:
AG00331U
Chemical Name:
2,6-Dimethylaniline HCl
CAS Number:
21436-98-6
Molecular Formula:
C8H12ClN
Molecular Weight:
157.6406
MDL Number:
MFCD00060213
IUPAC Name:
2,6-dimethylaniline;hydrochloride
InChI:
InChI=1S/C8H11N.ClH/c1-6-4-3-5-7(2)8(6)9;/h3-5H,9H2,1-2H3;1H
InChI Key:
QNWMFJDRMZWZNN-UHFFFAOYSA-N
SMILES:
Cc1cccc(c1N)C.Cl
EC Number:
244-388-1
UNII:
695APM3L5Y
Properties
Complexity:
80.6  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
157.066g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
157.641g/mol
Monoisotopic Mass:
157.066g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
26A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Protective effects of ascorbic acid against the genetic and epigenetic alterations induced by 3,5-dimethylaminophenol in AA8 cells. Journal of applied toxicology : JAT 20150501
Genotoxicity of 2,6- and 3,5-dimethylaniline in cultured mammalian cells: the role of reactive oxygen species. Toxicological sciences : an official journal of the Society of Toxicology 20121101
Further investigations into the genotoxicity of 2,6-xylidine and one of its key metabolites. Regulatory toxicology and pharmacology : RTP 20120201
Kinetics of 2,6-dimethylaniline oxidation by various Fenton processes. Journal of hazardous materials 20110815
Oxidation of 2,6-dimethylaniline by the Fenton, electro-Fenton and photoelectro-Fenton processes. Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering 20110101
Effect of carrier composition on 2,6-dimethylaniline degradation in aqueous solution by fluidized-bed Fenton process. Environmental technology 20110101
Third-order nonlinear optical properties and structures of (E)-N-(4-nitrobenzylidene)-2,6-dimethylaniline and (E)-N-(4-nitrobenzylidene)-2,3-dimethylaniline. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100501
Chemical oxidation of 2,6-dimethylaniline by electrochemically generated Fenton's reagent. Journal of hazardous materials 20100415
Kinetics and mechanism of 2,6-dimethyl-aniline degradation by hydroxyl radicals. Journal of hazardous materials 20091230
Chemical oxidation of 2,6-dimethylaniline in the fenton process. Environmental science & technology 20091115
Iron-catalyzed dehydrogenative phosphonation of N,N-dimethylanilines. Chemical communications (Cambridge, England) 20091028
Separation and analysis of dimethylaniline isomers by supercritical fluid chromatography--electrospray ionization tandem mass spectrometry. Journal of chromatography. A 20091009
Kinetics of 2,6-dimethylaniline degradation by electro-Fenton process. Journal of hazardous materials 20090130
Retention time prediction of compounds in Grob standard mixture for apolar capillary columns in temperature-programmed gas chromatography. Analytical and bioanalytical chemistry 20090101
Assessment of the medicines lidocaine, prilocaine, and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues. Drug metabolism and disposition: the biological fate of chemicals 20080801
Temperature investigations of E/Z isomers in ketimines based of p-dibenzoylobenzene with aniline and 2,6-dimethylaniline by infrared spectroscopy. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20071001
DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice. Chemical research in toxicology 20060801
Changes in production of lignin degrading enzymes during interactions between mycelia of the tropical decomposer basidiomycetes Marasmiellus troyanus and Marasmius pallescens. Mycological research 20060201
Metabolic activation of 2,6-xylidine in the nasal olfactory mucosa and the mucosa of the upper alimentary and respiratory tracts in rats. Toxicological sciences : an official journal of the Society of Toxicology 20041001
Liquid phase overtone spectral investigations of 2,6-dimethylaniline and 2,4-dimethylaniline-evidence for steric nature of the ortho effect and the consequent base weakening. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20040801
Synthesis, structure and pharmacology of acyl-2,6-xylidines. Acta poloniae pharmaceutica 20040101
Pharmacokinetics of xylazine, 2,6-dimethylaniline, and tolazoline in tissues from yearling cattle and milk from mature dairy cows after sedation with xylazine hydrochloride and reversal with tolazoline hydrochloride. Veterinary therapeutics : research in applied veterinary medicine 20030101
The effect of deuterium and fluorine substitution upon the mutagenicity of N-hydroxy-2,6-dimethylaniline. Mutation research 20020930
Lack of DNA binding in the rat nasal mucosa and other tissues of the nasal toxicants roflumilast, a phosphodiesterase 4 inhibitor, and a metabolite, 4-amino-3,5-dichloropyridine, in contrast to the nasal carcinogen 2,6-dimethylaniline. Drug and chemical toxicology 20020201
Determination of 2,6-dimethylaniline and o-toluidine impurities in preparations for local anaesthesia by the HPLC method with amperometric detection. Acta poloniae pharmaceutica 20020101
Oxidation of 2,6-dimethylaniline by recombinant human cytochrome P450s and human liver microsomes. Chemical research in toxicology 20010601
Plasma levels of lidocaine and prilocaine after application of Oraqix, a new intrapocket anesthetic, in patients with advanced periodontitis. Journal of clinical periodontology 20010501
Synthesis, characterization, and comparative 32P-postlabeling efficiencies of 2,6-dimethylaniline-DNA adducts. Chemical research in toxicology 20010201
Immunohistochemical and ultrastructural studies of 2,6-dimethylaniline-induced nasal proliferative lesions in a rat two-stage nasal carcinogenesis model initiated with N-bis(2-hydroxypropyl)nitrosamine. Toxicologic pathology 20010101
Analysis of the lidocaine metabolite 2,6-dimethylaniline in bovine and human milk. Journal of analytical toxicology 20010101
Sequential observation of 2,6-dimethylaniline-induced nasal lesions in a rat two-stage nasal carcinogenesis model after initiation with N-bis(2-hydroxypropyl) nitrosamine. The Journal of veterinary medical science 20000701
Tumor-promoting activity of 2,6-dimethylaniline in a two-stage nasal carcinogenesis model in N-bis(2-hydroxypropyl)nitrosamine-treated rats. Cancer letters 19990803
Properties